Industry Veteran Mike Guarino Named CEO of EVERSANA INTOUCH

Why It Matters

Guarino’s appointment accelerates EVERSANA’s AI‑enabled, insight‑driven approach, giving pharma clients a more integrated path to market. It signals heightened competition among life‑science agencies to deliver data‑rich, digital‑first campaigns.

Key Takeaways

• Mike Guarino appointed CEO of EVERSANA INTOUCH
• Guarino previously CCO at IPG Health, driving growth
• Focus on data, AI integration across life‑science marketing
• Founder Faruk Capan shifts to AI Agency platform expansion
• Agency aims to modernize insight‑driven strategies for pharma brands

Pulse Analysis

EVERSANA's decision to place Mike Guarino at the helm of its INTOUCH division reflects a broader industry shift toward data‑centric, AI‑powered marketing. Guarino brings two decades of agency leadership, most recently as chief commercial officer at IPG Health, where he championed growth through digital transformation. His track record of building high‑performing teams aligns with EVERSANA's ambition to deliver modern, insight‑driven strategies that resonate with healthcare professionals and patients alike.

The appointment comes as EVERSANA INTOUCH doubles down on artificial intelligence, leveraging the AI Agency platform launched in partnership with Google Cloud. This platform, which integrates advanced analytics, machine learning, and real‑time data, promises to streamline campaign planning, optimize media spend, and personalize outreach at scale. By embedding AI across its service stack, EVERSANA aims to turn complex commercialization challenges into actionable insights, a capability increasingly demanded by pharmaceutical brands navigating a fragmented digital landscape.

For life‑science companies, the leadership change signals a more cohesive, technology‑first partner capable of accelerating product launches and market penetration. As competitors race to embed AI into their offerings, EVERSANA's focus on integrated solutions could set a new benchmark for agency performance. Clients can expect faster decision cycles, deeper audience segmentation, and measurable ROI, positioning EVERSANA INTOUCH as a strategic ally in the evolving pharma marketing ecosystem.